Projects per year
Personal profile
Personal profile
Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.
Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.
Research Area Keywords
- Cancer
- Clinical Translation & Trials
- Molecular Medicine
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Shah, S.
3/30/23 → …
Project: Clinical Trial
-
ER stress response and chronic lymphocytic leukemia
Hu, C. A., Chaaya, G., Pingali, S. R. & Tang, C. A.
9/3/21 → …
Project: Clinical Trial
-
Targeting ER stress response in B-cell chronic lymphocytic leukemia
Hu, C. A., Pingali, S. R. & Tang, C. A.
4/1/21 → 3/31/25
Project: Federal Funding Agencies
-
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
Mai, S., Hodges, A., Chen, H. M., Zhang, J., Wang, Y. L., Liu, Y., Nakatsu, F., Wang, X., Fang, J., Xu, Y., Davidov, V., Kang, K., Pingali, S. R., Ganguly, S., Suzuki, M., Konopleva, M., Prinzing, B., Zu, Y., Gottschalk, S., Lu, Y., & 2 others , Dec 15 2023, In: Cancer research. 83, 24, p. 4047-4062 16 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
Burns, E. A., Sanchez, C. G., Mathur, S., Guerrero, C., Muhsen, I. N., Sarfraz, H., Hu, C. C. A., Tang, C. H. A., Shah, S. S., Tremont, I. W., Teh, B., Ganguly, S. & Pingali, S. R. K., May 2023, In: Annals of Hematology. 102, 5, p. 1111-1120 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Burns, E. A., Wilson, J. J., Mathur, S., Kieser, R., Gong, Z., Hu, C. C. A., Tang, C. H. A., Petkova, J., Yuen, C., Mai, H., Shah, S., Rice, L., Ganguly, S. & Pingali, S. R., Oct 2023, In: Annals of Hematology. 102, 10, p. 2753-2763 11 p.Research output: Contribution to journal › Article › peer-review
-
Prognostic Effect of Systemic Therapy and Radiation Therapy in Stage I Nodal Marginal Zone Lymphoma
Chevli, N., Margolis, V., Haque, W., Pingali, S. R., Butler, E. B. & Teh, B. S., Jan 1 2023, In: Practical Radiation Oncology. 13, 1, p. e80-e93Research output: Contribution to journal › Article › peer-review
-
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Su, P., Xiao, L., Ye, L., Wang, Z., Xiong, W., Wang, Q., Ma, X., Xian, M., Yang, M., Zu, Y., Pingali, S. R., Qian, J. & Yi, Q., May 7 2022, In: Journal of Hematology and Oncology. 15, 1, p. 55 55.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations